PT Kalbe Farma Tbk. (OTCMKTS:PTKFF) Stock Price Up 4.2%

PT Kalbe Farma Tbk. (OTCMKTS:PTKFFGet Rating) shares rose 4.2% during mid-day trading on Friday . The stock traded as high as $0.11 and last traded at $0.11. Approximately 700 shares changed hands during mid-day trading, a decline of 69% from the average daily volume of 2,293 shares. The stock had previously closed at $0.11.

PT Kalbe Farma Tbk. Price Performance

The company’s 50-day moving average is $0.11 and its 200-day moving average is $0.11.

About PT Kalbe Farma Tbk.

(Get Rating)

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. It offers generic, branded, and licensed drugs, including Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG that are distributed to hospitals, pharmacies, and drug stores.

Further Reading

Receive News & Ratings for PT Kalbe Farma Tbk. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PT Kalbe Farma Tbk. and related companies with MarketBeat.com's FREE daily email newsletter.